Literature DB >> 2896356

Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells.

W J Rettig1, P Garin-Chesa, H R Beresford, H F Oettgen, M R Melamed, L J Old.   

Abstract

Normal differentiation and malignant transformation of human cells are characterized by specific changes in surface antigen phenotype. In the present study, we have defined six cell-surface antigens of human sarcomas and normal mesenchymal cells, by using mixed hemadsorption assays and immunochemical methods for the analysis of cultured cells and immunohistochemical staining for the analysis of normal tissues and greater than 200 tumor specimens. Differential patterns of F19 (Mr, 120,000/95,000 glycoprotein), F24 (Mr, 95,000 glycoprotein), G171 (Mr, 75,000 glycoprotein), G253 (Mr, 90,000 glycoprotein), S5 (Mr, 120,000 glycoprotein), and Thy-1 (Mr, 25,000 glycoprotein) antigen expression were found to characterize (i) subsets of cultured sarcoma cell lines, (ii) cultured fibroblasts derived from various organs, (iii) normal resting and activated mesenchymal tissues, and (iv) sarcoma and nonmesenchymal tumor tissues. These results provide a basic surface antigenic map for cultured mesenchymal cells and mesenchymal tissues and permit the classification of human sarcomas according to their antigenic phenotypes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2896356      PMCID: PMC280153          DOI: 10.1073/pnas.85.9.3110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  High-molecular-weight glycoproteins of human teratocarcinoma defined by monoclonal antibodies to carbohydrate determinants.

Authors:  W J Rettig; C Cordon-Cardo; J S Ng; H F Oettgen; L J Old; K O Lloyd
Journal:  Cancer Res       Date:  1985-02       Impact factor: 12.701

2.  Extracellular matrix-modulated expression of human cell surface glycoproteins A42 and J143. Intrinsic and extrinsic signals determine antigenic phenotype.

Authors:  W J Rettig; V V Murty; M J Mattes; R S Chaganti; L J Old
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

Review 3.  Neuronal cell Thy-1 glycoprotein: homology with immunoglobulin.

Authors:  A F Williams; J Gagnon
Journal:  Science       Date:  1982-05-14       Impact factor: 47.728

4.  Surface antigen differentiation during human myogenesis in culture.

Authors:  F S Walsh; M A Ritter
Journal:  Nature       Date:  1981-01-01       Impact factor: 49.962

5.  Cell surface antigen of human neuroblastomas is related to nuclear antigen of normal cells.

Authors:  W J Rettig; P G Chesa; M T Jennings; B A Spengler; M R Melamed; H F Oettgen; J L Biedler; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

6.  Regulation of Thy-1 gene expression in transgenic mice.

Authors:  J W Gordon; P G Chesa; H Nishimura; W J Rettig; J E Maccari; T Endo; E Seravalli; T Seki; J Silver
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

7.  Differential expression of cell surface antigens and glial fibrillary acidic protein in human astrocytoma subsets.

Authors:  W J Rettig; P G Chesa; H R Beresford; H J Feickert; M T Jennings; J Cohen; H F Oettgen; L J Old
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

8.  Expression of cytokeratins in normal and neoplastic colonic epithelial cells. Implications for cellular differentiation and carcinogenesis.

Authors:  P G Chesa; W J Rettig; M R Melamed
Journal:  Am J Surg Pathol       Date:  1986-12       Impact factor: 6.394

9.  Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets.

Authors:  A N Houghton; M Eisinger; A P Albino; J G Cairncross; L J Old
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

10.  Role of human chromosome 11 in determining surface antigenic phenotype of normal and malignant cells. Somatic cell genetic analysis of eight antigens, including putative human Thy-1.

Authors:  W J Rettig; N C Dracopoli; P G Chesa; B A Spengler; H R Beresford; P Davies; J L Biedler; L J Old
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

View more
  71 in total

1.  Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin.

Authors:  Aaron M LeBeau; W Nathaniel Brennen; Saurabh Aggarwal; Samuel R Denmeade
Journal:  Mol Cancer Ther       Date:  2009-05-05       Impact factor: 6.261

2.  Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, III, and IV.

Authors:  Victoria J Christiansen; Kenneth W Jackson; Kyung N Lee; Patrick A McKee
Journal:  Arch Biochem Biophys       Date:  2006-11-17       Impact factor: 4.013

3.  [Construction of a eukaryotic expression vector of fibroblast activation protein and establishment of its stable over-expression in the oral squamous cell carcinoma].

Authors:  Zhao Meng; Shao Tingru; Huang Jiaxin; Chen Yuechuan; Lv Xiaozhi
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2017-10-01

4.  Cell surface molecules of human melanoma. Immunohistochemical analysis of the gp57, GD3, and mel-CSPG antigenic systems.

Authors:  P Garin-Chesa; H R Beresford; A Carrato-Mena; H F Oettgen; L J Old; M R Melamed; W J Rettig
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

5.  Fibroblast activation protein increases metastatic potential of fibrosarcoma line HT1080 through upregulation of integrin-mediated signaling pathways.

Authors:  Sarah K Baird; Laura Allan; Christoph Renner; Fiona E Scott; Andrew M Scott
Journal:  Clin Exp Metastasis       Date:  2015-05-21       Impact factor: 5.150

6.  Activatable near-infrared fluorescent probe for in vivo imaging of fibroblast activation protein-alpha.

Authors:  Jinbo Li; Kai Chen; Hongguang Liu; Kai Cheng; Meng Yang; Jiping Zhang; Jonathan D Cheng; Yan Zhang; Zhen Cheng
Journal:  Bioconjug Chem       Date:  2012-07-31       Impact factor: 4.774

7.  Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma.

Authors:  Petr Busek; Eva Balaziova; Ivana Matrasova; Marek Hilser; Robert Tomas; Martin Syrucek; Zuzana Zemanova; Evzen Krepela; Jaromir Belacek; Aleksi Sedo
Journal:  Tumour Biol       Date:  2016-08-04

8.  Targeted disruption of mouse fibroblast activation protein.

Authors:  J Niedermeyer; M Kriz; F Hilberg; P Garin-Chesa; U Bamberger; M C Lenter; J Park; B Viertel; H Püschner; M Mauz; W J Rettig; A Schnapp
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

9.  Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity.

Authors:  Liang-Chuan S Wang; Albert Lo; John Scholler; Jing Sun; Rajrupa S Majumdar; Veena Kapoor; Michael Antzis; Cody E Cotner; Laura A Johnson; Amy C Durham; Charalambos C Solomides; Carl H June; Ellen Puré; Steven M Albelda
Journal:  Cancer Immunol Res       Date:  2013-11-12       Impact factor: 11.151

10.  Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours.

Authors:  Osamu Dohi; Haruo Ohtani; Masahito Hatori; Elichi Sato; Masami Hosaka; Hiroshi Nagura; Eiji Itoi; Shoichi Kokubun
Journal:  Histopathology       Date:  2009-10       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.